LIVN LivaNova PLC

  1. Stocks
  2. Healthcare
  3. NASDAQ: LIVN

Price (delayed)

$39.5

Market cap

$2.15B

P/E Ratio

33.76

Dividend/share

N/A

EPS

$1.17

Enterprise value

$2.09B

LivaNova PLC is a global medical technology and innovation company built on nearly five decades of experience and a relentless commitment to provide hope for patients and their families through ...

Highlights
The net income has soared by 167% from the previous quarter
LivaNova's EPS has surged by 166% QoQ
LivaNova's quick ratio has decreased by 12% QoQ
LIVN's debt is up by 6% year-on-year
Sector: Healthcare
Industry: Medical Devices
Website: http://www.livanova.com
Peers: NVRO OFIX NURO

Key stats

What are the main financial stats of LIVN
Market
Shares outstanding
54.35M
Market cap
$2.15B
Enterprise value
$2.09B
Valuations
Price to earnings (P/E)
33.76
Price to book (P/B)
1.62
Price to sales (P/S)
1.71
EV/EBIT
13.82
EV/EBITDA
10.33
EV/Sales
1.67
Earnings
Revenue
$1.25B
Gross profit
$870.87M
Operating income
$129.05M
Net income
$63.23M
EBIT
$151.36M
EBITDA
$202.51M
Free cash flow
$135.93M
Per share
EPS
$1.17
EPS diluted
$1.16
Free cash flow per share
$2.51
Book value per share
$24.31
Revenue per share
$23.11
TBVPS
$28.01
Balance sheet
Total assets
$2.51B
Total liabilities
$1.19B
Debt
$667.73M
Equity
$1.32B
Working capital
$735.06M
Liquidity
Debt to equity
0.51
Current ratio
2.87
Quick ratio
2.34
Net debt/EBITDA
-0.28
Margins
EBITDA margin
16.2%
Gross margin
69.5%
Net margin
5%
Operating margin
10.3%
Efficiency
Return on assets
2.5%
Return on equity
5%
Return on invested capital
13.2%
Return on capital employed
7.2%
Return on sales
12.1%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

LIVN stock price

How has the LivaNova stock price performed over time
Intraday
1.2%
1 week
-1%
1 month
-5.12%
1 year
-27.28%
YTD
-14.71%
QTD
0.56%

Financial performance

How have LivaNova's revenue and profit performed over time
Revenue
$1.25B
Gross profit
$870.87M
Operating income
$129.05M
Net income
$63.23M
Gross margin
69.5%
Net margin
5%
The net income has soared by 167% from the previous quarter
LIVN's net margin has soared by 163% since the previous quarter
The gross profit has grown by 13% YoY and by 3.5% from the previous quarter
LivaNova's revenue has increased by 9% YoY

Growth

What is LivaNova's growth rate over time

Valuation

What is LivaNova stock price valuation
LIVN P/E details
P/E
33.76
P/B
1.62
P/S
1.71
EV/EBIT
13.82
EV/EBITDA
10.33
EV/Sales
1.67
LivaNova's EPS has surged by 166% QoQ
The price to book (P/B) is 38% lower than the 5-year quarterly average of 2.6 and 27% lower than the last 4 quarters average of 2.2
The equity rose by 3.3% year-on-year
The price to sales (P/S) is 44% lower than the 5-year quarterly average of 3.0 and 27% lower than the last 4 quarters average of 2.3
LivaNova's revenue has increased by 9% YoY

Efficiency

How efficient is LivaNova business performance
The return on equity has surged by 163% since the previous quarter
The company's return on assets has surged by 150% QoQ

Dividends

What is LIVN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for LIVN.

Financial health

How did LivaNova financials performed over time
The company's total assets is 111% higher than its total liabilities
The current ratio has declined by 15% since the previous quarter and by 2.7% year-on-year
LivaNova's quick ratio has decreased by 12% QoQ
LIVN's debt is 49% smaller than its equity
LIVN's debt is up by 6% year-on-year
LIVN's debt to equity is up by 4.1% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.